INTRODUCTION
Solitary fibrous tumors (SFTs) are a rare type of spindle cell neoplasm, composed of cellular and collagenous components. It was first described in 1931 and originally believed to be only of pleural origin, SFTs have been reported in organs such as the meninges, orbit, thyroid, upper respiratory tract, peritoneum, retroperitoneum, kidneys, parotid glands, and soft tissues [1] [2] [3] . It may arise in the liver from the inner layer of its capsule or from the intrahepatic fibrous connective tissue [2] . Its development in the liver is considered uncommon.
Despite many reports on malignant cases, some with local recurrences and metastatic propagation, most SFTs of the liver (SFTL) are benign [4] . The site of origin is responsible for the variability in its clinical presentation [5] . The diagnosis is based on histological and morphological characteristics, associated with immunohistochemical markers and molecular analysis [1] [2] [3] .
The recommended management of SFTL is surgical resection. Despite it, SFTs can recur and spread and have reported 10-year overall survival rates of 54-89% after a complete surgical resection [6] .
We report a case of a SFTL with a review of the literature, using information from the English and Spanish scientific literature available in PubMed. The keywords "solitary fibrous tumor" and "hepatic" or "liver" had been used. Hepatic localization was described in 69 articles, the relevant ones were retrieved, reviewed, and analyzed (56 publications).
CASE REPORT
A 42-year-old woman presented with right hypochondrial discomfort and postprandial fullness, 18 months ago. At the physical examination, the abdomen was semi-globose and painful to diffuse deep palpation, with more pronounced pain in right hypochondrium laboratory tests indicated: red blood cells 2.99 million/mm 3 ; hemoglobin 8.9 g/dL; hematocrit 26%; transaminase AST/TGO: 110 U/L; transaminase ALT/ TGP: 308 U/L; alkaline phosphatase: 219.8 U/L; Gamma-GT: 86.3 U/L; C-reactive protein: 29.7 mL/L. Magnetic nuclear resonance of the upper abdomen showing nodular expansive formation with well-defined contours and limits in T1-weighted sequence, hyposignal in T1 and T2, located in the superomedial segment of the left hepatic lobe, presenting nodular contrast enhancement, opacified in phase late study, measuring approximately 3.6×3.1 cm. Insidious evolution, after three years of detection by imaging examination (according to information collected -incidental detection of hepatic nodule through abdominal ultrasound), left hepatectomy was performed. Surgical procedure without complications, with hospital discharge after six days.
Gross examination revealed a nodular mass, white color, firm and elastic, measuring 3.2x3.0 cm. Microscopic examination evidenced fusocellular proliferation, hypocellular and hypercellular areas (mild atypia), with predominance of a sclerotic pattern, sometimes outlining angiomatoid spaces and surrounding epithelial cells of ductular arrangement (Figure 1 A-F) .
The immunohistochemical study revealed ki-67 1%, positivity for STAT6, CD34, and Bcl-2 ( Figure 2 A-D). The diagnosis was of solitary fibrous tumor of liver.
DISCUSSION
Solitary fibrous tumors is a neoplasm often reported occurring in the pleura and mediastinum, having a mesenchymal origin. Its development in the liver is considered relatively rare [7, 8] . Due to the distinct possibilities of origin of SFT of the liver (Glisson's capsule or intrahepatic connective tissue), this neoplasm may present as a pedunculated tumor or as an intraparenchymal mass [7] . SFT is considered a benign tumor with the potential for malignant transformation [9] .
There are no known predisposing factors to the SFTL, which is a form of borderline tumor [7] . Most cases of SFT have a benign behavior, with higher frequency of malignancy when they originate in the pleura [8] .
Eighty five cases of SFTL have been reported in the medical literature, since 1958 to 2018, including this report. The side of the liver where the tumor presents itself does not seem to have a predisposition. The mean age of occurrence of the tumor is 56.9 (range 16-87), with predominance toward 55.9% women. 17.6% of cases showed malignant features. No cases reported in cirrhotic livers.
The clinical presentation of the symptoms is variable, related to the size of the tumor and the anatomical structures involved by it [7] . They were abdominal pain, vomiting, anorexia, abdominal distension, postprandial fullness, weight loss, and fatigue [10] . Hypoglycemia may be a finding, being part of the paraneoplastic syndrome in which there is production of insulin-like growth factor, tending to return to normal parameter after surgical treatment [11, 12] . Biochemical laboratory tests do not tend to present variation [10] .
Imaging shows most lesions are single, large, wellcircumscribed, and heterogeneous, but it is not present in all patients as typical radiological features [10] . The imaging tests are no diagnostic and do not determine the behavior of the neoplasm, as in most tumors with mesenchymal line, being helpful to exclude invasion and elucidate the relationship between the tumor and neighboring structures [13] . The admixed cellular and collagenous components likely to be responsible for the heterogeneous enhancement on imaging [11] . Abdominal ultrasound mostly reveals a well-defined, hypoechogenic, or hyperechogenic mass. The hypodensity may be confirmed by the computed tomography (CT) scans, with or without irregular minimal enhancement. Magnetic resonance imaging (MRI) complements the image evaluation, showing hypointense masses on T1-weighted investigations and hyperintense areas on T2-weighted MRI images [14] .
Macroscopically, most SFTs of the liver were described like as firm and elastic, white-to-gray, and well defined and delimited by a soft, thick, fibrous whitish or graywhite capsule [8, 14] . When cut, fasciculate, irregular, yellowish and whitish areas interspersed with soft areas and focal myxoid degeneration may be observed, besides areas of cystic degeneration, necrosis, or bleeding [8] . Grossly, the tumors varied in size from 1.5 to 45 cm in greatest diameter.
Within the diagnostic procedures, the percutaneous liver biopsy guided by radiation is not indicated, because it evaluates only part of the lesion, and some features of it can be missed. In addition, there is a risk of the tumor spreading through the puncture site [7] .
The surgical resection is the management of choice to treat SFTL. Other approaches eventually are performed, such as radiotherapy, transhepatic arterial embolization, adjuvant chemotherapy, or conservative treatment [12] . The diagnosis is based on histological and morphological characteristics, associated with immunohistochemical markers and molecular analysis [1] [2] [3] 8] .
Under microscopy, many architectural patterns can be seen. The most frequent is a "patternless" pattern of spindle cells, showing fields sometimes with hypocellularity, sometimes with hypercellularity, interposed by bands of collagenous tissue. It can be noted a relation that how higher the total collagen, lower cellularity [7, 10] . Necrosis can be frequently observed in both malignant and benign cases. Mitotic figures, atypia, nuclear pleomorphism, and prominent nucleoli are observed in malignant tumors. The absence of mitoses or inflammatory cells in the benign SFT is relevant, although in these cases there may be little atypia or cellular plemorphism [8] .
The differential diagnosis leiomyoma, hepatic metastatic gastrointestinal stromal tumors (GISTs), hepatic angiomyolipoma, sarcoma hepatocellular carcinoma, inflammatory pseudotumor, inflammatory myofibroblastic tumor of the liver and hemangiopericytoma, peripheral nerve sheath tumor, with some entities one of substantial value, given their potential risk of metastasis and local dissemination [7, 12, 13] .
In relation to immunohistochemistry, the monoclonal antibody CD34, which is a favorable endothelial cell marker, is considered as a differential marker between SFTL and other unusual spindle-cell neoplasms. But CD34 also stains some neoplasms, such as gastrointestinal stromal tumor, neural tumor, and some smooth muscle tumors, being necessary to associate with other antibody markers for which solitary fibrous tumor immunoreacts. Besides being positive for CD34, SFTLs are also positive to CD99, Bcl-2, epithelial membrane antigen, and smooth muscle α-actin. Benign SFTLs have a ki-67 positivity in 5% or less of their cells. It is suggested a ki-67 higher than 5% as a marker of malignancy [8, 12, 14] .
It was recently identified the signal transduction and activator of transcription 6 (STAT6). The etiology of SFTL is attributed to mutations of the NAB2 and STAT6 genes located on chromosomal region 12q13 [3] . Almost 100% of SFTs harbor an NAB2-STAT6 fusion gene, which is considered specific to this tumor type as a very specific immunohistochemical marker para discern SFT from other similar entities. STAT6 nuclear expression in SFT was reported in our case. The tumors that originate from nervous, muscular, or epithelial tissue may be necessarily excluded, assisted by immunohistochemical markers including STAT6, CD34, VI, Bcl-2, NSE, CD99, SMA, CK18, and others [12, 15] .
Hypercellularity, high mitotic activity, tumor necrosis, cytologic anaplasia, and/or nuclear atypia are suggestive of malignancy. The presence of metastatic lesions is indicative of malignancy too. In cases with mitotic index above 4/10 high power fields, local or distant recurrence is more frequent. Another predictor of recurrence also reported was tumor size [10] .
The most important prognostic factor is resectability and the presence of tumor-free margins in order to prevent local or distant recurrence [10, 14] . No further treatment usually is required if the tumor is confined to the liver [14] .
It is difficult to determine the long-term prognosis of this entity given the small number of patients and the absence of long-term follow-up. The main concern in such cases is that SFT can develop malignant transformation. The risk of malignancy is not extremely low (around 10% of reported cases), meaning that SFTL carries a real risk of malignant transformation [10, 11, 14] . Univariate analysis indicates that nuclear atypia/pleomorphism, high mitotic index, extrapleural location, p53-positive staining, and the presence of telomerase reverse transcriptase (TERT) mutation are associated with lower survival rates [12] .
CONCLUSION
It is an uncommon neoplasm, with only 85 cases reported in the English Literature including the present case. The clinical presentation is habitually indolent. The diagnosis is based on histological and morphological characteristics, associated with immunohistochemical markers and molecular analysis. The rarity of this tumor makes it difficult to evaluate its prognosis and natural course. Surgical resection remains the mainstay of treatment and appears to be curative of most cases.
